ABSTRACT

Objectives:

We aimed to show the possible effect of the peritoneal dialysis (PD) modality on the mood and clinical outcomes of the patients during the first official quarantine period applied to control the Coronavirus disease-2019 (COVID-19) in Turkey.

Materials and Methods:

With the start of quarantine, in our center, we started doing the patient visits by phone. At the end of the quarantine, the patients were asked to complete a questionnaire in order to reveal whether they felt safe or alone, their anxiety status, and their preferred method of communicating with the team. In addition, volume status, biochemical parameters, blood pressure and medications in December 2019 were reviewed and compared with those in June 2020.

Results:

A total of 60 patients, 32 of whom were female, with a mean age of 53.4±16 years were included in the study. While there were 24 (40%) patients who underwent remote controlled outpatient peritoneal dialysis (RK-APD), there were 36 (60%) patients who underwent continuous APD (CAPD). According to the survey results, 15 (25%) patients did not experience any anxiety, while 45 patients stated that they had varying degrees of anxiety. 85% of the patients reported that they were very pleased that they could continue their dialysis treatment at home. While 69.4% of the patients who underwent CAPD were worried that they could not be followed as closely during the quarantine, 70.8% of the patients who underwent RK-APD stated that they felt safe because their treatment was monitored by the team through the system. While there was only an increase in the daily amount of ultrafiltration in RK-APD patients (December 2019 and June 2020; 1,365 vs 1,514 mL, p=0.026), no difference was observed in CAPD patients. CAPD patients tended to communicate with nurses more frequently. While these interviews were done frequently via WhatsApp messages in CAPD patients (20, 37% vs 5, 18.5%; p=0.008), they were in the form of audio phone calls (22, 81%) in APD patients.

Conclusion:

In conclusion, during the COVID-19 outbreak, maintaining dialysis with PD treatment at home, regardless of the modality, is a safe and effective method and has positive effects on patient satisfaction.

Keywords: Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis, COVID-19, Telemedicine

References

Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829-838.

Ikizler TA. COVID-19 in dialysis patients: adding a few more pieces to the puzzle. Kidney Int. 2020;98:17-19.

Ikizler TA. COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do? Am J Kidney Dis. 2020;76:1-3.

Goicoechea M, Sánchez Cámara LA, Macías N, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98:27-34.

Boen ST, Mion CM, Curtis FK, et al. Periodic peritoneal dialysis using the repeated puncture technique and an automatic cycling machine. Trans Am Soc Artif Intern Organs. 1964;10:409-414.

Giuliani A, Crepaldi C, Milan Manani S, et al. Evolution of Automated Peritoneal Dialysis Machines.Contrip Nephrol. 2019;197:9-16.

Brown E, Arteaga JD, Chow J, et al. ISPD: Strategies regarding COVID-19 in PD patients adapted from Peking University First Hospital 28th Mar 2020. [Available from: http://ispd.org/wp-content/uploads/ISPD-PD-management-in-COVID-19_ENG.pdf].

Derneği TN. Renal Afet Gücü Önerileri- COVID 19 ve Hemodiyaliz 2020 [Available from: http://www.nefroloji.org.tr/haber.php?id=283.

Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.

Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52:1193-1194.

Bro S, Bjorner JB, Tofte-Jensen P, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int. 1999;19:526-533.

Rabindranath KS, Adams J, Ali TZ, et al. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev. 2007;2007:CD006515.

Milan Manani S, Rosner MH, Virzì GM, et al. Longitudinal Experience with Remote Monitoring for Automated Peritoneal Dialysis Patients. Nephron. 2019;142:1-9.

Makhija D, Alscher MD, Becker S, et al. Remote Monitoring of Automated Peritoneal Dialysis Patients: Assessing Clinical and Economic Value. Telemed J E Health. 2018;24:315-323.

Yeter HH, Akcay OF, Ronco C, et al. Automated Remote Monitoring for Peritoneal Dialysis and Its Impact on Blood Pressure. Cardiorenal Med. 2020;10:198-208.

El Shamy O, Tran H, Sharma S, et al. Telenephrology with Remote Peritoneal Dialysis Monitoring during Coronavirus Disease 19. Am J Nephrol. 2020;51:480-482.

Bunch A, Ardila F, Castaño R, et al. Through the Storm: Automated Peritoneal Dialysis with Remote Patient Monitoring during COVID-19 Pandemic. Blood Purif. 2020:1-4.

Chen J, Yin L, Chen X, et al. Management of peritoneal dialysis under COVID-19: The experience in Sichuan Province People’s Hospital, China. Perit Dial Int. 2021;41:42-48.

Yeter HH, Gok Oguz E, Akcay OF, et al. The reliability and success of peritoneal dialysis during the COVID-19 pandemic. Semin Dial. 2021;34:147-156.

Comparison of Remote Controlled Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis During COVID-19 Pandemic

ABSTRACT

References